We use cookies to improve your experience and for marketing. Read our cookie policy or manage cookies.
Labcorp surpasses Q4 2024 revenue expectations with a 9.8% year-over-year increase, fueled by strong demand in healthcare diagnostics and strategic growth initiatives.
ArcelorMittal pushes for stronger EU trade protections due to rising Chinese steel imports and high production costs, while advocating for green investments.
U.S. jobless claims unexpectedly rose, yet the labor market remains robust, as reported by the Labor Department.
Zimmer Biomet faces currency challenges, projecting lower 2025 profits. Despite exceeding Q4 sales expectations, future earnings are anticipated to be below Wall Street forecasts.
The Czech Central Bank has cut its key interest rate to 3.75% to address high inflation and support economic growth, as European economies face similar challenges.
UK landlords are grappling with rising property insurance costs and restrictive coverage, affecting the buy-to-let market's viability.
Arrow Electronics' Q4 2024 results show mixed performance with revenue exceeding expectations but experiencing a decline in sales and cautious guidance for future quarters.
AGCO Corporation's Q4 CY2024 results missed Wall Street expectations with a 24% revenue drop and GAAP loss of $3.42 per share.
MasterCraft defied market odds with a strong Q4 CY2024 performance, exceeding revenue expectations despite a sales drop, thanks to its premium XStar lineup.
Eli Lilly reports strong Q4 2024 earnings, boosts 2025 guidance; driven by impressive GLP-1 drug sales, it remains an attractive investment opportunity.
MACOM Technology Solutions delivered strong Q4 2024 results with significant revenue growth, highlighting its strategic positioning in the semiconductor market.
Ralph Lauren reports a 10.8% revenue growth in Q4 CY2024, surpassing expectations and marking a positive turnaround with high profitability.
63
